OP0268 COMPARISON OF MAJOR CARDIOVASCULAR AND THROMBOEMBOLIC EVENTS IN SAFETY REPORTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH JAK INHIBITORS VERSUS ANTI-TNF: RESULTS FROM VigiBase
François Montastruc, Clara Flumian, Y. Degboe, A. Constantin, A. Ruyssen-Witrand
Topics & Concepts
MedicineTofacitinibRheumatoid arthritisGolimumabAdalimumabEtanerceptInfliximabCertolizumab pegolInternal medicineTocilizumabOdds ratioPsoriatic arthritisSurgeryTumor necrosis factor alphaRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchChronic Lymphocytic Leukemia Research